23 Results for "

GPVI

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "GPVI" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-109091
CAS No.: 1800046-95-0
Purity:  99.13%
Synonyms: GS-9876
Target:  

Syk

Research Areas:  

Inflammation/Immunology Cancer

Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib (GS-9876) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99644
CAS No.: 2101829-58-5

Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

ACT017 is a Fab fragment of humanized anti-GPVI monoclonal antibody. ACT017 inhibits collagen-induced platelet aggregation. ACT017 has the potential for the research of acute ischemic stroke .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109091B
CAS No.: 1800047-00-0
Purity:  98.58%
Synonyms: GS-9876 succinate
Target:  

Syk

Research Areas:  

Inflammation/Immunology Cancer

Lanraplenib succinate (GS-9876 succinate) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib succinate (GS-9876 succinate) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-144390
CAS No.: 1327156-14-8
Purity:  99.78%
Synonyms: GPVI antagonist 1
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

(S)-S007-1558 (compound 5) is a glycoprotein VI (GPVI) platelet receptor antagonist. (S)-S007-1558 inhibits collagen-induced platelet aggregation with an IC50 of 25.3 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P77952
Purity:  ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: GPVI; Gp6; Glycoprotein 6; MGC138168
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70180
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuGlycoprotein 6 (Platelet)/GPVI, His ; Glycoprotein 6; glycoprotein VI (platelet); GP6; GPIV; GPVI; GPVIplatelet collagen receptor; MGC138168; platelet glycoprotein VI
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-103094
CAS No.: 172895-39-5
Purity:  99.60%
Target:  

5-HT Receptor

Research Areas:  

Inflammation/Immunology

LY266097 hydrochloride is a selective 5-HT2B receptor antagonist with pKis of 7.7, 9.8, and 7.6 for 5-HT2A, 5-HT2B, 5-HT2C, respectively. 5-HT2B receptor blockade contributes to the research in depression .
loading...
    loading...
Cat. No.: HY-112386
CAS No.: 622387-85-3
Purity:  95.00%
Target:  

Syk

Research Areas:  

Inflammation/Immunology

OXSI-2 is a bioavailable, cell-permeable Syk inhibitor with an EC50 of 313 nM and an IC50 of 14 nM .
loading...
    loading...
Cat. No.: HY-115911
CAS No.: 880399-00-8
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

GPVI antagonist 2 (Compound 1) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 2 are, respectively, 0.35 μM for collagen, 0.80 μM for CRP, 195.2 μM for convulxin and 81.38 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 2 is a promising antiplatelet agent .
loading...
    loading...
Cat. No.: HY-115912
CAS No.: 901654-94-2
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

GPVI antagonist 3 (Compound 2) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 3 are, respectively, 1.01 μM for collagen, 1.92 μM for CRP, 7.24 μM for convulxin and 51.74 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 3 is a promising antiplatelet agent .
loading...
    loading...
Cat. No.: HY-B1308
CAS No.: 62-13-5
Target:  

Adrenergic Receptor

Adrenalone hydrochloride is an adrenergic agonist used as a topical vasoconstrictor and hemostatic. Adrenalone hydrochloride is an inhibitor of dopamine β oxidase. Adrenalone hydrochloride is chemically similar to known norepinephrine transporter (NET) ligands with an IC50 of 36.9 μM .
loading...
    loading...
Cat. No.: HY-B1308A
CAS No.: 99-45-6
Target:  

Adrenergic Receptor

Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic. Adrenalone is an inhibitor of dopamine β oxidase. Adrenalone is chemically similar to known norepinephrine transporter (NET) ligands with an IC50 of 36.9 μM .
loading...
    loading...
Cat. No.: HY-RS05611
Research Areas:  

Others

GP6 Human Pre-designed siRNA Set A contains three designed siRNAs for GP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P10949
CAS No.: 1159846-95-3
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

Pep-10L peptide is a glycoprotein VI (GPVI) antagonist with Ki values of 180, 225, and 179 μM for CPR, GPO-1, and Type 1 collagen, respectively. Pep-10L peptide has anti-thrombotic effects .
loading...
    loading...
Cat. No.: HY-109091A
CAS No.: 1800046-97-2
Synonyms: GS-9876 monosuccinate
Target:  

Syk

Research Areas:  

Inflammation/Immunology Cancer

Lanraplenib monosuccinate (GS-9876 monosuccinate) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib monosuccinate (GS-9876 monosuccinate) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .
loading...
    loading...
Cat. No.: HY-B1308R
CAS No.: 62-13-5
Adrenalone (hydrochloride) (Standard) is the analytical standard of Adrenalone (hydrochloride). This product is intended for research and analytical applications. Adrenalone hydrochloride is an adrenergic agonist used as a topical vasoconstrictor and hemostatic. Adrenalone hydrochloride is an inhibitor of dopamine β oxidase. Adrenalone hydrochloride is chemically similar to known norepinephrine transporter (NET) ligands with an IC50 of 36.9 μM .
loading...
    loading...
Cat. No.: HY-P700732
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GPVI; Gp6; Glycoprotein 6; MGC138168
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS17621
Research Areas:  

Others

Gp6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gp6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-184940
Target:  

Btk Glycoprotein VI PKC

Research Areas:  

Cardiovascular Disease

BTK-IN-50 is a covalent BTK inhibitor with an IC50 of 6 nM. BTK-IN-50 blocks collagen-induced platelet aggregation by inhibiting the GPVI-mediated BTK-PLCγ2-PKC signaling cascade, and attenuates CRP-XL-induced phosphorylation of BTK, PLCγ2 and PKC substrates in platelets. BTK-IN-50 can be used for research related to thrombosis .
loading...
    loading...
Cat. No.: HY-109091R
CAS No.: 1800046-95-0
Synonyms: GS-9876 (Standard)
Target:  

Reference Standards Syk

Research Areas:  

Inflammation/Immunology Cancer

Lanraplenib (Standard) is the analytical standard of Lanraplenib (HY-109091). This product is intended for research and analytical applications. Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib (GS-9876) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .
loading...
    loading...